Change of lot or extension of reference standard shelf-life is considered low risk and should be downgraded from prior-approval to being managed in the Pharmaceutical Quality System (PQS) only based on a science and risk-based approach.
Delphine Collete
Advertisement
Delphine Collete is global subject matter expert for QC Materials Management at GSK Vaccines.
Articles by Delphine Collete
Advertisement
Latest Updated Articles
Advertisement
Advertisement
